Evidence map›Paper›PMID 19481676›Full record

ArticleMutation research2009

Cockayne syndrome group B protein is engaged in processing of DNA adducts of lipid peroxidation product trans-4-hydroxy-2-nonenal.

Leena Maddukuri, Elzbieta Speina, Mette Christiansen, Dominika Dudzińska, Jolanta Zaim, Tomasz Obtułowicz, Sylwia Kabaczyk, Marek Komisarski, Zuzanna Bukowy, Jadwiga Szczegielniak and 5 more

Open access · greenAbstract read
In one paragraph

Article in Mutation research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. DNA repair deficiency in neurodegeneration.Progress in neurobiology · 2011
    Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Leena MaddukuriInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, 02-106 Warsaw, Poland.
Elzbieta Speina
Mette Christiansen
Dominika Dudzińska
Jolanta Zaim
Tomasz Obtułowicz
Sylwia Kabaczyk
Marek Komisarski
Zuzanna Bukowy
Jadwiga Szczegielniak
Andrzej Wójcik
Jaroslaw T Kuśmierek
Tinna Stevnsner
Vilhelm A Bohr
Barbara Tudek
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLUniversity of Warsaw · PLDanish Pain Research Center · DKInstytut Chemii i Techniki Jądrowej · PLNational Institute on Aging · USPostgraduate School of Molecular Medicine · PL

Funding

The role of the Cockayne syndrome proteinZIAAG000722 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2023
$9.1M
Oxidative DNA Damage And Its ProcessingZIAAG000727 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2022
$8.4M
Michigan Pregnancy Risk Assessment and Monitoring System (MI PRAMS)U01DP003131 · DP · MICHIGAN STATE DEPARTMENT OF HEALTH AND HUMAN SERVICES · PI MCKANE, PATTI · 2011 to 2015
$617k
ACL HHS U01DP003131Intramural NIH HHS ZIA AG000722NCCDPHP CDC HHS U01 DP003131
6 · The paper itself

Abstract

Cockayne syndrome complementation group B (CSB) protein is engaged in transcription-coupled repair (TCR) of UV induced DNA damage and its deficiency leads to progressive multisystem degeneration and premature aging. Here, we show that human CSB-deficient cells are hypersensitive to physiological concentrations (1-10 microM) of a lipid peroxidation product, trans-4-hydroxy-2-nonenal (HNE), and in response to HNE they develop a higher level of sister chromatid exchanges (SCEs) in comparison to the wild-type cells. HNE-DNA adducts block in vitro transcription by T7 RNA polymerase, as well as by HeLa cell-free extracts. Treatment of wild-type cells with 1-20 microM HNE causes dephosphorylation of the CSB protein, which stimulates its ATPase activity necessary for TCR. However, high HNE concentrations (100-200 microM) inhibit in vitro CSB ATPase activity as well as the transcription machinery in HeLa cell-free extracts. Cell lines expressing CSB protein mutated in different ATPase domains exhibit different sensitivities to HNE. The motif II mutant, which binds ATP, but is defective in ATP hydrolysis was as sensitive to HNE as CSB-null cells. In contrast, motif V mutant cells were as sensitive to HNE as were the cells bearing wild-type protein, while motif VI mutant cells showed intermediate sensitivity to HNE. These mutants exhibit decreased ATP binding, but retain residual ATPase activity. Homology modeling suggested that amino acids mutated in motifs II and VI are localized closer to the ATP binding site than amino acids mutated in ATPase motif V. These results suggest that HNE-DNA adducts are extremely toxic endogenous DNA lesion, and that their processing involves CSB. When these lesions are not removed from the transcribed DNA strand due to CSB gene mutation or CSB protein inactivation by high, pathological HNE concentrations, they may contribute to accelerated aging.

Indexed as

AldehydesDNA AdductsDNA HelicasesDNA Repair EnzymesHeLa CellsHumansLipid PeroxidationModels, MolecularMutationPhosphorylationPoly-ADP-Ribose Binding ProteinsSister Chromatid ExchangeTranscription, Genetic4-hydroxy-2-nonenalAldehydesDNA AdductsDNA HelicasesDNA Repair EnzymesERCC6 protein, humanPoly-ADP-Ribose Binding Proteins

Identifiers

PMID19481676
PMCPMC4586250
OpenAlexW2010217149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.